Literature DB >> 2889486

Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1,365.

M Kalafatis1, Y Takahashi, J P Girma, D Meyer.   

Abstract

A collagen-binding domain of von Willebrand factor (vWF) has been identified in the central part of the molecule by comparing the binding properties of vWF and Staphylococcus aureus V-8 protease-generated vWF fragments with collagen. The binding of purified human vWF to human type III collagen was found to be specific. At saturation, 38 to 50.2 micrograms of vWF bound per milligram of collagen. Scatchard plots derived from binding isotherms demonstrated the presence of at least two classes of binding sites. Purified vWF was digested with S aureus V-8 protease into two complementary fragments (SpIII and SpII). SpII, the C-terminal end of vWF (amino acid residues 1,366 to 2,050), was totally devoid of affinity for collagen. Contrarily, purified SpIII, the N-terminal part of vWF (residues 1 to 1,365), totally displaced vWF binding and specifically bound to collagen. At saturation, 25 to 45 micrograms of SpIII bound per milligram of collagen. Scatchard plots demonstrated the presence of a single class of binding sites. SpIII was further digested with the same enzyme to generate SpI, a 52-kilodalton fragment from the C-terminal part of SpIII (residues 911 to 1,365). Spl induced a dose-dependent inhibition of both vWF and SpIII binding to collagen. A series of six monoclonal antibodies against SpIII that completely abolished vWF and SpIII interaction with collagen also bound to SpI. In conclusion, SpI extending between amino acid residues 911 and 1,365 of vWF contains a specific site that interacts with human type III collagen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889486

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis.

Authors:  Takayuki Nakayama; Tadashi Matsushita; Koji Yamamoto; Noriko Mutsuga; Tetsuhito Kojima; Akira Katsumi; Norihiko Nakao; J Evan Sadler; Tomoki Naoe; Hidehiko Saito
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

Review 2.  Molecular genetics of type 2 von Willebrand disease.

Authors:  Edith Fressinaud; Claudine Mazurier; Dominique Meyer
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

3.  GPIbα-vWF rolling under shear stress shows differences between type 2B and 2M von Willebrand disease.

Authors:  L A Coburn; V S Damaraju; S Dozic; S G Eskin; M A Cruz; L V McIntire
Journal:  Biophys J       Date:  2011-01-19       Impact factor: 4.033

4.  Von Willebrand factor-A1 domain binds platelet glycoprotein Ibα in multiple states with distinctive force-dependent dissociation kinetics.

Authors:  Lining Ju; Yunfeng Chen; Fangyuan Zhou; Hang Lu; Miguel A Cruz; Cheng Zhu
Journal:  Thromb Res       Date:  2015-06-20       Impact factor: 3.944

5.  Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.

Authors:  S Layet; J P Girma; B Obert; E Peynaud-Debayle; N Bihoreau; D Meyer
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

6.  Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.

Authors:  Koichi Kokame; Masanori Matsumoto; Kenji Soejima; Hideo Yagi; Hiromichi Ishizashi; Masahisa Funato; Hiroshi Tamai; Mutsuko Konno; Kei Kamide; Yuhei Kawano; Toshiyuki Miyata; Yoshihiro Fujimura
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

7.  Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin.

Authors:  M F Hoylaerts; K Nuyts; K Peerlinck; H Deckmyn; J Vermylen
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

8.  The globular domains of type VI collagen are related to the collagen-binding domains of cartilage matrix protein and von Willebrand factor.

Authors:  E Koller; K H Winterhalter; B Trueb
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

Review 9.  COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm.

Authors:  Yoshihiro Fujimura; Linda Z Holland
Journal:  Int J Hematol       Date:  2022-03-22       Impact factor: 2.319

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.